Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion type Assertion NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_head.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion description "[The cytokine LIGHT activates various anti-tumor functions through its two receptors, lymphotoxin beta receptor (LTbetaR) and herpes virus entry mediator (HVEM), and is expected to be a promising candidate for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_provenance.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion evidence source_evidence_literature NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_provenance.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion SIO_000772 20117833 NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_provenance.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion wasDerivedFrom befree-20140225 NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_provenance.
- NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_assertion wasGeneratedBy ECO_0000203 NP857330.RARmjon_NGBWsS_h8NArR4L4zpi3RPnvEm7-FqO3YyLaA130_provenance.